[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Becker et al., 2010 - Google Patents

Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics

Becker et al., 2010

View HTML
Document ID
2253579906557751628
Author
Becker G
Sielaff F
Than M
Lindberg I
Routhier S
Day R
Lu Y
Garten W
Steinmetzer T
Publication year
Publication venue
Journal of medicinal chemistry

External Links

Snippet

Furin belongs to the family of proprotein convertases (PCs) and is involved in numerous normal physiological and pathogenic processes, such as viral propagation, bacterial toxin activation, cancer, and metastasis. Furin and related furin-like PCs cleave their substrates at …
Continue reading at pmc.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4813—Exopeptidases (3.4.11. to 3.4.19)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP

Similar Documents

Publication Publication Date Title
Becker et al. Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics
Osman et al. Why all the fury over furin?
Leung et al. Protease inhibitors: current status and future prospects
Wang et al. Hydrolysis and transport of egg white-derived peptides in Caco-2 cell monolayers and everted rat sacs
Otto et al. Cysteine proteases and their inhibitors
Becker et al. Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases
Weigel et al. Phenylalanine and phenylglycine analogues as arginine mimetics in dengue protease inhibitors
Stoermer et al. Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity
Skinner-Adams et al. Identification of phosphinate dipeptide analog inhibitors directed against the Plasmodium falciparum M17 leucine aminopeptidase as lead antimalarial compounds
Steinkühler et al. Product inhibition of the hepatitis C virus NS3 protease
Velmourougane et al. Synthesis of new (−)-bestatin-based inhibitor libraries reveals a novel binding mode in the S1 pocket of the essential malaria M1 metalloaminopeptidase
de Veer et al. Improving the selectivity of engineered protease inhibitors: optimizing the P2 prime residue using a versatile cyclic peptide library
Kwiatkowska et al. Design, synthesis, and structure–activity relationship studies of a potent PACE4 inhibitor
Winiarski et al. Human neutrophil elastase phosphonic inhibitors with improved potency of action
Gagnon et al. Optimization of furin inhibitors to protect against the activation of influenza hemagglutinin H5 and Shiga toxin
Fan et al. Stability and transport of spent hen-derived ACE-inhibitory peptides IWHHT, IWH, and IW in human intestinal Caco-2 cell monolayers
Dahms et al. Structural studies revealed active site distortions of human furin by a small molecule inhibitor
Houstecka et al. Biomimetic Macrocyclic Inhibitors of Human Cathepsin D: Structure–Activity Relationship and Binding Mode Analysis
Ivanova et al. Optimization of substrate‐analogue furin inhibitors
Swedberg et al. Highly potent and selective plasmin inhibitors based on the sunflower trypsin inhibitor-1 scaffold attenuate fibrinolysis in plasma
Saupe et al. Development of new cyclic plasmin inhibitors with excellent potency and selectivity
Remacle et al. Selective and potent furin inhibitors protect cells from anthrax without significant toxicity
Steinmetzer et al. The antiviral potential of host protease inhibitors
Lam van et al. The basicity makes the difference: improved canavanine-derived inhibitors of the proprotein convertase furin
Rahman et al. Discovery of first-in-class peptidomimetic neurolysin activators possessing enhanced brain penetration and stability